Let’s See New Treatments


It is safe to say the Ice Bucket Challenge in the summer of 2014 forever changed the future and trajectory of ALS. The awareness and funds generated by the social media phenomenon put us on a path to end this disease once and for all.

Prior to the Challenge, there was only one available treatment option for people living with ALS, as well as a few other therapies to help manage symptoms.

Kuldip Dave
What the Ice Bucket Challenge did was put ALS on the map. It created a recognition for a rare disease that wasn't there before.”
Dr. Kuldip Dave
Senior vice president of research at the ALS Association
finding treatments image

In the last 10 years, we have seen an influx of researchers and companies striving to discover new treatments and cures for ALS. The result of these efforts has been six FDA approvals for new drugs and new drug formulations, including the first antisense oligonucleotide (ASO) for the treatment of ALS.

We were the first to fund research of ALS-specific ASOs back in 2004 when it was just emerging, despite the high risk of the technology not coming to fruition. We subsequently committed more than $1.3 million to ASO technology and funded five additional studies, including preclinical, safety and pharmacodynamic measurements, and the first-in-human phase 1 trial assessing safety and target engagement for an early SOD1-targeting antisense drug.

These studies supported continued investigation of SOD1 as a therapeutic target and led to the development of the more potent antisense drug Qalsody (tofersen), which was approved to treat SOD1-ALS in 2023

Larry Falivena
Every opportunity to make a new treatment available that can stop or slow down this disease is a win for the whole community.”
Larry Falivena
ALS Association Board of Trustee Member Living with SOD1-ALS

Since the Ice Bucket Challenge, ALS research continues to gain momentum. More than 40 genes linked to ALS have been discovered. We understand more about the biological pathways and processes that drive disease development and progression than ever before. And, as a result, more than 50 potential treatments are in the clinical stage of development, including more than a dozen in phase 3 trials.

Clinical Trials

To make ALS a livable disease and ultimately find a cure, we continue working to increase the number of clinical trials and make it easier for more people to participate in those trials. By expanding clinical trial capacity, we can improve trial accessibility for people with ALS in underserved areas and help potential new therapies to be tested faster. 

“If we can find two dozen treatments that allow people with ALS to live, that it is no longer a death sentence, that they can take two or three or four or five drugs together, and that means now they can live longer and they can speak and they can breathe and they can move, that's what livable means to us,” says Dr. Dave.

It's finding new treatments and cures. It's optimizing current treatments and care and preventing loved ones from getting ALS in the first place.”
Dr. Kuldip Dave
Senior vice president of research at the ALS Association
Ice Bucket Challenge

Despite the progress we’ve made, our work is not done.

We still need more treatments.

We still need a cure.

Let's See It End.

To learn more about the research we fund, visit our website HERE. And to continue to follow the latest ALS research news, sign up for our monthly newsletter, Research Matters.

Join us this summer at ALS Nexus, a conference featuring a variety of sessions that focus on the latest developments and opportunities in research, care, and advocacy. Learn more and register TODAY!

To continue to follow stories about people living with ALS in the community and learn more about the disease, subscribe to receive our weekly blogs in your inbox HERE or follow us at als.org/blog.


We Want to Hear from You!
Your feedback is important to us. Please let us know what you think about our blog – take this short survey and provide your input and feedback.


Submitted by: Michael T. on Thu, 05/09/2024

My wife was diagnosed in 2015. All the trials we see are for people that have an 18 month or less diagnosis. Will there ever be trials for individuals that have been living with this disease for many years?

Thank you

Submitted by: Stephanie O. on Fri, 05/24/2024

Hello Michael,

With the way ALS clinical trials are currently designed, a large portion of people living with the disease are unfortunately ineligible to participate. However, clinical trial design is always evolving so this could change. It may be helpful to reach out to the Northeast ALS Consortium (NEALS) clinical trial liaison by calling 855-437-4823 or emailing alstrials@neals.org to discuss your specific situation and what options might be available.

Submitted by: Christine S. on Thu, 06/06/2024

I have been diagnosed with Familial ALS, which killed my sister after 3 years, my father before her and my Grandfather before him , are there any trials for those not afflicted with SOD1, C9

Join the conversation. Please comment below.

1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.